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Non-cirrhotic portal hypertension
entity in South Africa?
A report of 6 cases




Six patients with portal hypertension and well-preserved liver
function as well as classic features of non-cirrhotic portal
hypertension on histological examination of biopsy specimens
are described. Three of these patients also had extrahepatic
portal vein occlusion. All patients had varying degrees of
portal hypertension and hypersplenism. Three patients under-
went sple~ectomy a~d the remainder had sclerotherapy to
control variceal bleeding. The overall prognosis is excellent if
variceal bleeding can be controlled by appropriate measures.
~ence recognition of this infrequently diagnosed entity is
Important for an accurate prognosis and appropriate thera-
peutic interventions.
S Atr Med J 1991: 79: 268-270.
Non-cirrhotic portal hypertension (NCPH) is a relatively
uncommon and probably underdiagnosed disease in Western
countries. l It appears to be more common in India and in
Japan, where it accounts for 25 - 30% of all cases of portal
hypertension. 2 NCPH has Qeen known under various names:
non-cirrhotic portal fibrosis;3 hepatoportal sclerosis,4 idiopathic
portal hypertension;5 obliterative portal vein obstruction and
obliterative portal venopathy. 6 This distinct syndro~e is
characterised by portal hypertension without evidence of liver
cirrhosis, and the fearures of the disease resemble those of
chronic schistosomiasis.7
The diagnosis of NCPH should be considered in the presence
?f lor:g-standing splenomegaly and also repeated gastro-
mtestmal haemorrhages with preserved or minimally deranged
hepatocellular function. The diagnosis is also dependent on
the exclusion of more usual causes of portal hypertension by
appropriate investigations.
In NCPH the surface of the liver is occasionally nodular
and described at the time of laparotomy as resembling 'early
cirrhosis'.4 On histological examination the condition is charac-
teris~d by.the presence of dilated veins, periportal angiomatosis,
. varymg degrees of portal fibrosis and phlebosclerotic oblitera-
tive lesions of the terminal portal vein branches.7 One of the
most complete early reports8 also described irregular capsular
thickening, thickening of some portal tracts with radiating fine
fibrous septa, and distortion of the lobular architecture with
hyperplasia and compression of other areas. Sinusoidal
collagenisation, sinusoidal dilatation with or without cellular
infiltrates, and cellular inflammatory infiltrates in portal tracts
have also been reported.8,9 .
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The aetiology of NCPH is largely obscure. There are associa-
tions with arsenical, vinyl chloride or copper poisoning.2 Recent
reports include protein C deficiency or chronic overdose of
vitamin A as additional possible causative factors. lo
Patients and methods
During 1989 6 patients with NCPH, 2 men and 4 women,
were seen at the Liver Clinic, Groote Schuur Hospital, for
evaluation of clinical fearures suggestive of portal hypertension
and splenomegaly. Their ages varied from 23 years to 50 years
(mean age 35,3 years) and all had signs of portal hypertension
with oesophageal varices and splenomegaly or a .history of
splenectomy (Table I).
Two patients had undergone splenectomy, and varIceal bleeds
h~d been recorded in 4 patients. Chronic haemolytic anaemia
With hepatomegaly was noted in 1 patient. Patients 3 and 6
had diabetes mellirus and patient 5 had chronic ··pancreatitis.·
~epatic wedge biopsies from 2 patients had been previously
dlagnose,j as unspecified liver fibrosis and micronodular
cirrhosis.
All patients had characteristically normal or mildly chole-
statically deranged liver function tests (Table II). Patients 5
and 6 had a history of gastric peptic ulcer disease and gallst~mes.
Fearures of chronic liver disease, such as ascites, palmar
erythema, jaundice, fever, gytlaecomastia, testicular atrophy
and Dupuytren's contracture, were not present in any patient.
Needle biopsy specimens from all patients were available
and, in addition, wedge biopsies were taken from 3 patients.
The fearures seen on histological examination and collated in
Table III show a regular appearance of fibrosis and/or sclerosis
of portal vein branches, fibrous septa radiating from the portal
tracts, dilatation of branches of portal and terminal veins (Figs
1 - 4), irregular distribution of blood vessels or periportal hyper-'
vascularity (Fig. 3), and areas of hepatocyte hyperplasia with
Fig. 1. Low-power view of the liver (patient 4) with non-cirrhotic
portal hypertension. Note irregular periportal fibrosis, dilated and
irr~u~arly distributed portal vein branches, fine fibrous septa
radiating between lobules and nodularity (Reticulin X 35).
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TABLE I. BASIC CLINICAL INFORMATION
Patient Age (yrs), sex Clinical diagnosis Duration (yrsJ Portal vein
1 24, F S,OVB, P 9 moo Occluded
2 19, F S, SCT, OVB 1 Patent
3 50, M S,O
,
2 Patent
4 28, M S,OVB 3,5 Occluded
5 43, F SCT, OVB, 0 28 Occluded
6 48, F SCT, 0 19 Patent
s = splenomegaly and/or hepatosplenomegaly; SCT = splenectomy; ova ~ oesophageal variceal bleeding;





128 - 24347 - 218 0001,2 - 1,9
TABLE 11. COAGULATION AND LIVER FUNCTION TESTS
Prothrombin index Platelets (X 109 /1) ALP
1 180 - 400 000 30 - 115
.1,0 - 1,5 52 - 500 000· 126 - 141
Normal range
NCPH (N = 3)
NCPH + occluded
portal vein (N =3)
• After splenectomy.
ALP = alkaline phosphatase; GGT = gammaglutamyltransferase.
TABLE Ill. HISTOLOGICAL EXAMINATION OF BIOPSIES
Fibrosis Vein dilatation
Type of Sub- Portal Septal Portal Terminal Areas of
Patient biopsy capsular branches hyperplasia Other
1 Needle ? + - + + + + - Dilated sinusoids
2 Needle, +++ +++ ++ + + + Irregular distribution of veins
wedge with Zenker's infarct
3 Needle, + + ++ + Portal round-cell infiltration
wedge of irregular distribution
4 Needle ++ + +++ ++ + ++ Nil
wedge
5 Needle ? + ++ + + + Sinusoidal dilation with
collagenisation
6 Needle ? + ++ + + Irregular distribution of veins
Fig. 2. Tru~Cut biopsy from patient 2 shows an enlarged, sclerotic
portal tract. Portal vein is narrowed and replaced by numerous
thin-walled channels (lower right corner). On the left is dilated
terminal hepatic vein (H and EX 210).
Fig. 3. Broadening and fibrosis of portal tract, periportal angio-
matosis in wedge biopsy from patient 2 (H and E X 240).
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Fig. 4. Tru-Cut liver biopsy (patient 3) shows moderate fatty
changes and sclerosis of portal vein branches (upper right corner)
(H and E X 240).
compression of adjacent lobular structures (Fig. 2). Less
common features were sinusoidal dilatation or collagenisation,
portal round-cell infiltrates, and intrahepatic portal vein throm-
bosis with consecutive hepatocyte atrophy (Zenker's infarct)."
Cirrhotic nodular rearrangement of the lobular architecture
or features characteristic of schistosomiasis, such as ponal
calcification, parasitic ova or reactive granulomas, were noted.
Pronounced septal fibrosis was a feature of all 3 wedge biopsies
and irregular capsular thickening was also evident in 2 biopsies.
Based on these histological and clinical features, the possi-
bility of NCPH was considered. Further ultrasonography and
angiography revealed occlusion of ponal veins in 3 patients.
No evidence of other intra- or extrahepatic causes of ponal
hypenension was found.
There was no apparent association with arsenical, vinyl
cWoride, copper, toxins or alcohol poisoning. The course of
the disease was relatively benign in all patients, except for
patient 1, who bled massively from grade IV varices and died
from an oesophageal perforation and haemoperitoneum after
sclerotherapy.
Discussion
Six cases of NCPH were diagnosed at Groote Schuur Hospital
in 1989. The paucity of description of this disease in previous
hospital records indicates that NCPH has not been recognised
as such and is thus probably underdiagnosed. Histological
examination of hepatic specimens, particularly wedge biopsies,
is crucial for the diagnosis and, indeed, Kingham er al. 1have
stated that the diagnosis of NCPH is entirely based on histo-
logical evidence. In our experience close collaboration between
members of the Departments of Medicine, Radiology and
Pathology is necessary to establish this diagnosis. The inter-
pretation of a single needle biopsy may lead to the diagnosis of
incomplete septal cirrhosis,11 unspecified fibrosis, macronodular
cirrhosis or no abnormality at all. The results of exclusively
extrahepatic portal vein obstruction, such as ponal vein throm-
bosis, include parenchyma! atrophy, dilated terminal hepatic
veins and minor ponal fibrosis. Differential diagnoses include
schistosomiasis, nodular regenerative hyperplasia, and peri-
sinusoidal fibrosis of a toxic or alcoholic nature.2 A long-tenn
follow-up study of NCPHl has indicated a relatively good
prognosis compared with portal hypenension related to other
disease processes. Two of our patients (cases 2 and 4) with 19
and 28 years' history of the disease, respectively, confirm the
excellent life expectancy if death from haemorrhage can be
prevented by appropriate measures.
In conclusion, we emphasise that NCPH is probably under-
diagnosed in South Mrica and that proper diagnosis is impor-
tant because of the very different prognosis from that of
cirrhosis with ponal hypenension.
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